Tina Marriott Larson's Insider Trades & SAST Disclosures

Tina Marriott Larson's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 14,286 Class A Common Stock done at an average price of $6.2 . Disclosure was reported to the exchange on Nov. 15, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.17 per share. 15 Nov 2024 14,286 506,852 - 6.2 88,216 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Oct 2024 6,000 452,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 6.31 per share. 24 Oct 2024 6,000 521,138 - 6.3 37,855 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 24 Oct 2024 6,000 527,138 - 1.1 6,360 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 26 Sep 2024 6,000 527,138 - 1.1 6,360 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 7.00 per share. 26 Sep 2024 6,000 521,138 - 7.0 42,005 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 29 Aug 2024 6,000 527,138 - 1.1 6,360 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 7.56 per share. 29 Aug 2024 6,000 521,138 - 7.6 45,376 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Aug 2024 6,000 464,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.69 per share. 15 Aug 2024 14,319 521,138 - 6.7 95,794 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 8.13 per share. 25 Jul 2024 6,000 535,457 - 8.1 48,809 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 25 Jul 2024 6,000 541,457 - 1.1 6,360 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2024 6,000 470,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2024 6,000 476,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 7.22 per share. 27 Jun 2024 6,000 535,457 - 7.2 43,290 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 27 Jun 2024 6,000 541,457 - 1.1 6,360 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 30 May 2024 3,000 538,457 - 1.1 3,180 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 8.78 per share. 30 May 2024 3,000 535,457 - 8.8 26,325 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.01 per share. 15 May 2024 9,998 533,233 - 10.0 100,080 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Apr 2024 3,000 485,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 7.67 per share. 25 Apr 2024 3,000 543,231 - 7.7 23,021 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 25 Apr 2024 3,000 546,231 - 1.1 3,180 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 21 Mar 2024 8,000 647,982 - 1.1 8,480 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Mar 2024 8,000 488,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 10.70 per share. 21 Mar 2024 7,390 640,592 - 10.7 79,065 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 11.34 per share. 21 Mar 2024 610 639,982 - 11.3 6,915 Class A Common Stock
Recursion Pharmaceuticals ...
Marriott Larson Tina President and COO Sale of securities on an exchange or to another person at price $ 14.90 per share. 22 Feb 2024 8,000 639,982 - 14.9 119,160 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Larson Marriott President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Feb 2024 8,000 496,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Marriott Larson Tina President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 22 Feb 2024 8,000 647,982 - 1.1 8,480 Class A Common Stock
Recursion Pharmaceuticals ...
Larson Tina Marriott President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.43 per share. 15 Feb 2024 5,379 639,982 - 12.4 66,861 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 447,917 447,917 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Larson Tina Marriott President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 223,958 648,161 - 0 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Larson Marriott President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 9,655 424,203 - 0 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.09 per share. 09 Feb 2024 2,800 645,361 - 10.1 28,252 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2024 8,000 504,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Larson Marriott Tina President and COO Sale of securities on an exchange or to another person at price $ 10.35 per share. 25 Jan 2024 8,000 414,548 - 10.3 82,762 Class A Common Stock
Recursion Pharmaceuticals ...
Larson Tina Marriott President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 25 Jan 2024 8,000 422,584 - 1.1 8,480 Class A Common Stock
Recursion Pharmaceuticals ...
Larson Marriott Tina President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Dec 2023 8,000 512,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Larson Tina Marriott President and COO Sale of securities on an exchange or to another person at price $ 10.58 per share. 28 Dec 2023 8,000 414,548 - 10.6 84,654 Class A Common Stock
Recursion Pharmaceuticals ...
Marriott Tina Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 28 Dec 2023 8,000 422,548 - 1.1 8,480 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 24 Aug 2023 3,000 421,782 - 1.1 3,180 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Aug 2023 3,000 529,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 8.64 per share. 24 Aug 2023 2,937 418,845 - 8.6 25,373 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 9.46 per share. 24 Aug 2023 63 418,782 - 9.5 596 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.18 per share. 15 Aug 2023 5,378 418,782 - 9.2 49,370 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jul 2023 8,000 532,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 27 Jul 2023 8,000 432,160 - 1.1 8,480 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 14.05 per share. 27 Jul 2023 4,373 424,160 - 14.0 61,424 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 13.12 per share. 27 Jul 2023 3,627 428,533 - 13.1 47,570 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 29 Jun 2023 3,000 427,160 - 1.1 3,180 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jun 2023 3,000 540,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 7.49 per share. 29 Jun 2023 3,000 424,160 - 7.5 22,470 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2023 3,000 543,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 31 May 2023 3,000 427,160 - 1.1 3,180 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 8.63 per share. 31 May 2023 3,000 424,160 - 8.6 25,888 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. 15 May 2023 5,415 422,429 - 5.6 30,324 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 7.82 per share. 23 Feb 2023 8,000 427,844 - 7.8 62,540 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 23 Feb 2023 8,000 435,844 - 1.1 8,480 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2023 8,000 546,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.44 per share. 15 Feb 2023 1,603 427,844 - 8.4 13,529 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 434,122 434,122 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 217,061 422,808 - 0 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 9,732 432,540 - 0 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.55 per share. 01 Feb 2023 3,093 429,447 - 8.5 26,445 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 8.07 per share. 26 Jan 2023 8,000 203,654 - 8.1 64,547 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 26 Jan 2023 8,000 211,654 - 1.1 8,480 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2023 8,000 554,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Dec 2022 8,000 562,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 7.70 per share. 29 Dec 2022 8,000 203,654 - 7.7 61,566 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 29 Dec 2022 8,000 211,654 - 1.1 8,480 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2022 16,000 570,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 10.96 per share. 15 Nov 2022 16,000 203,654 - 11.0 175,402 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 15 Nov 2022 16,000 219,654 - 1.1 16,960 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.86 per share. 15 Nov 2022 1,453 203,654 - 11.9 17,233 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 27 Oct 2022 16,000 221,107 - 1.1 16,960 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2022 16,000 586,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 10.72 per share. 27 Oct 2022 16,000 205,107 - 10.7 171,450 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Sep 2022 16,000 602,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 29 Sep 2022 16,000 221,107 - 1.1 16,960 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 10.86 per share. 29 Sep 2022 15,936 205,171 - 10.9 173,011 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 11.53 per share. 29 Sep 2022 64 205,107 - 11.5 738 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2022 16,000 618,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 12.60 per share. 15 Aug 2022 16,000 295,107 - 12.6 201,637 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 15 Aug 2022 16,000 221,107 - 1.1 16,960 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.96 per share. 15 Aug 2022 1,453 205,107 - 13.0 18,831 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. 16 May 2022 1,458 206,560 - 5.7 8,267 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2022 58,500 634,000 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 04 Mar 2022 58,500 208,018 - 1.1 62,010 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 18 Feb 2022 16,000 149,518 - 1.1 16,960 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2022 16,000 692,500 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2022 4,000 708,500 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 14 Feb 2022 4,000 133,518 - 1.1 4,240 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 159,226 159,226 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 79,613 127,954 - 0 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 4,784 4,784 - - Stock Option (Right to Buy)
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 2,392 130,346 - 0 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.40 per share. 04 Feb 2022 828 129,518 - 11.4 9,439 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 18.09 per share. 16 Dec 2021 1,160 48,840 - 18.1 20,983 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 19.17 per share. 16 Dec 2021 1,040 47,800 - 19.2 19,933 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 19.78 per share. 16 Dec 2021 300 47,500 - 19.8 5,933 Class A Common Stock
Recursion Pharmaceuticals ...
Tina Marriott Larson President and COO Sale of securities on an exchange or to another person at price $ 18.81 per share. 18 Nov 2021 1,798 50,702 - 18.8 33,828 Class A Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades